Syphilis Testing Market 2020-2024 | Increase in Prevalence of Syphilis to Boost Growth | Technavio

The Associated Press
The Associated Press

LONDON–(BUSINESS WIRE)–Mar 13, 2020–

Technavio has been monitoring the syphilis testing market and it is poised to grow by USD 0.42 bn during 2020-2024, progressing at a CAGR of over 2% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here:

Technavio has announced its latest market research report titled Global Syphilis Testing Market 2020-2024 (Graphic: Business Wire).

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. F. Hoffmann-La Roche AG, Hologic Inc., Omega Diagnostics Group Plc, Siemens Healthineers AG and Thermo Fisher Scientific Inc. are some of the major market participants. Although the increase in prevalence of syphilis will offer immense growth opportunities, high cost of syphilis diagnostic tests will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Increase in prevalence of syphilis has been instrumental in driving the growth of the market. However, high cost of syphilis diagnostic tests might hamper market growth.

Syphilis Testing Market is segmented as below:

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our report covers the following areas:

This study identifies increase in prevalence of CS as one of the prime reasons driving the syphilis testing market growth during the next few years.

We provide a detailed analysis of around 25 vendors operating in the syphilis testing market, including some of the vendors such as F. Hoffmann-La Roche AG, Hologic Inc., Omega Diagnostics Group Plc, Siemens Healthineers AG and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the syphilis testing market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:www.technavio.com/

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: INFECTIOUS DISEASES GENERAL HEALTH HEALTH MEDICAL SUPPLIES

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 03/13/2020 05:15 PM/DISC: 03/13/2020 05:15 PM

http://www.businesswire.com/news/home/20200313005282/en

COMMENTS

Please let us know if you're having issues with commenting.